US20070191780A1 - Drug delivery device - Google Patents

Drug delivery device Download PDF

Info

Publication number
US20070191780A1
US20070191780A1 US11/355,000 US35500006A US2007191780A1 US 20070191780 A1 US20070191780 A1 US 20070191780A1 US 35500006 A US35500006 A US 35500006A US 2007191780 A1 US2007191780 A1 US 2007191780A1
Authority
US
United States
Prior art keywords
reservoir
needle
housing
chamber
actuator
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US11/355,000
Inventor
Pankaj Modi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
PKA Softtouch Corp
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to US11/355,000 priority Critical patent/US20070191780A1/en
Priority to CA002536845A priority patent/CA2536845C/en
Assigned to PKA SOFTTOUCH CORP. reassignment PKA SOFTTOUCH CORP. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: MODI, PANKAJ
Priority to EP07701776.2A priority patent/EP1983964B1/en
Priority to JP2008554571A priority patent/JP5099370B2/en
Priority to PCT/CA2007/000225 priority patent/WO2007093051A1/en
Priority to AU2007215343A priority patent/AU2007215343B2/en
Priority to PL07701776T priority patent/PL1983964T3/en
Priority to ES07701776.2T priority patent/ES2440247T3/en
Priority to NZ570532A priority patent/NZ570532A/en
Priority to DK07701776.2T priority patent/DK1983964T3/en
Priority to BRPI0707845A priority patent/BRPI0707845B8/en
Publication of US20070191780A1 publication Critical patent/US20070191780A1/en
Priority to ZA200807006A priority patent/ZA200807006B/en
Priority to EC2008008681A priority patent/ECSP088681A/en
Priority to US13/229,538 priority patent/US8597257B2/en
Priority to US14/065,122 priority patent/US20140207078A1/en
Priority to US14/562,974 priority patent/US20150273152A1/en
Priority to US15/361,654 priority patent/US20170203051A1/en
Priority to US16/543,051 priority patent/US20200360625A1/en
Abandoned legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178Syringes
    • A61M5/31Details
    • A61M5/32Needles; Details of needles pertaining to their connection with syringe or hub; Accessories for bringing the needle into, or holding the needle on, the body; Devices for protection of needles
    • A61M5/3287Accessories for bringing the needle into the body; Automatic needle insertion
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178Syringes
    • A61M5/28Syringe ampoules or carpules, i.e. ampoules or carpules provided with a needle
    • A61M5/281Syringe ampoules or carpules, i.e. ampoules or carpules provided with a needle using emptying means to expel or eject media, e.g. pistons, deformation of the ampoule, or telescoping of the ampoule
    • A61M5/282Syringe ampoules or carpules, i.e. ampoules or carpules provided with a needle using emptying means to expel or eject media, e.g. pistons, deformation of the ampoule, or telescoping of the ampoule by compression of deformable ampoule or carpule wall
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178Syringes
    • A61M5/28Syringe ampoules or carpules, i.e. ampoules or carpules provided with a needle
    • A61M5/285Syringe ampoules or carpules, i.e. ampoules or carpules provided with a needle with sealing means to be broken or opened
    • A61M5/286Syringe ampoules or carpules, i.e. ampoules or carpules provided with a needle with sealing means to be broken or opened upon internal pressure increase, e.g. pierced or burst
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178Syringes
    • A61M5/28Syringe ampoules or carpules, i.e. ampoules or carpules provided with a needle
    • A61M5/285Syringe ampoules or carpules, i.e. ampoules or carpules provided with a needle with sealing means to be broken or opened
    • A61M5/288Syringe ampoules or carpules, i.e. ampoules or carpules provided with a needle with sealing means to be broken or opened by piercing without internal pressure increase
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/46Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests having means for controlling depth of insertion
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178Syringes
    • A61M5/31Details
    • A61M2005/3143Damping means for syringe components executing relative movements, e.g. retarders or attenuators slowing down or timing syringe mechanisms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178Syringes
    • A61M5/31Details
    • A61M5/32Needles; Details of needles pertaining to their connection with syringe or hub; Accessories for bringing the needle into, or holding the needle on, the body; Devices for protection of needles
    • A61M5/3205Apparatus for removing or disposing of used needles or syringes, e.g. containers; Means for protection against accidental injuries from used needles
    • A61M5/321Means for protection against accidental injuries by used needles
    • A61M5/3243Means for protection against accidental injuries by used needles being axially-extensible, e.g. protective sleeves coaxially slidable on the syringe barrel
    • A61M5/3245Constructional features thereof, e.g. to improve manipulation or functioning
    • A61M2005/3247Means to impede repositioning of protection sleeve from needle covering to needle uncovering position
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00General characteristics of the apparatus
    • A61M2205/60General characteristics of the apparatus with identification means
    • A61M2205/6063Optical identification systems
    • A61M2205/6081Colour codes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2207/00Methods of manufacture, assembly or production
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/002Packages specially adapted therefor, e.g. for syringes or needles, kits for diabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178Syringes
    • A61M5/24Ampoule syringes, i.e. syringes with needle for use in combination with replaceable ampoules or carpules, e.g. automatic
    • A61M5/2422Ampoule syringes, i.e. syringes with needle for use in combination with replaceable ampoules or carpules, e.g. automatic using emptying means to expel or eject media, e.g. pistons, deformation of the ampoule, or telescoping of the ampoule
    • A61M5/2425Ampoule syringes, i.e. syringes with needle for use in combination with replaceable ampoules or carpules, e.g. automatic using emptying means to expel or eject media, e.g. pistons, deformation of the ampoule, or telescoping of the ampoule by compression of deformable ampoule or carpule wall
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178Syringes
    • A61M5/31Details
    • A61M5/3129Syringe barrels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178Syringes
    • A61M5/31Details
    • A61M5/315Pistons; Piston-rods; Guiding, blocking or restricting the movement of the rod or piston; Appliances on the rod for facilitating dosing ; Dosing mechanisms
    • A61M5/31525Dosing
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178Syringes
    • A61M5/31Details
    • A61M5/32Needles; Details of needles pertaining to their connection with syringe or hub; Accessories for bringing the needle into, or holding the needle on, the body; Devices for protection of needles
    • A61M5/3205Apparatus for removing or disposing of used needles or syringes, e.g. containers; Means for protection against accidental injuries from used needles
    • A61M5/321Means for protection against accidental injuries by used needles
    • A61M5/3243Means for protection against accidental injuries by used needles being axially-extensible, e.g. protective sleeves coaxially slidable on the syringe barrel
    • A61M5/326Fully automatic sleeve extension, i.e. in which triggering of the sleeve does not require a deliberate action by the user

Definitions

  • the present invention relates to drug delivery devices and methods of delivering a drug intradermally.
  • the present invention relates to intradermal delivery of a liquid drug.
  • the skin comprises two layers, the outer or upper surface called the epidermis, and the internal surface referred to as the dermis.
  • the epidermis does not contain any blood vessels and it is dependent on the underlying dermis for nutrient delivery and waste disposal via diffusion.
  • the inner layer, the dermis is composed of two layers, the more superficial papillary dermis and the deeper reticular dermis.
  • the papillary dermis is thinner and consists primarily of loose connective tissue containing small capillaries, elastic fibers, reticular fibers and some collagen.
  • the deeper reticular dermis consists of a thicker connective tissue containing larger blood vessels, interlaced elastic fibers and core spindles of collagen fibers arranged in layers parallel to the surface.
  • the reticular layer also contains many antigen-presenting cells, fibroblasts, mast cells, nerve endings, and lymphatics. Because of the high amount of blood vessels, lymphatics and antigen presenting cells in the dermis, this is an ideal site for delivery of drugs and/or antigens.
  • the outer layer, the epidermis has a thickness of about 0.05 to 2 mm and the dermis has a thickness between about 1.5 and 4 mm.
  • the needle must penetrate the skin to a depth of no more than 5 mm, preferably between about 2 and 4 mm. It is very difficult to control an injection to this shallow depth.
  • a fine gauge needle is inserted at a 45° angle to try and get the agent into the dermis.
  • United States Patent Application No. 2005/0124967 is directed to a method for directly delivering a high molecular weight substance into an intradermal space within mammalian skin comprising administering the substance through at lease one hollow needle having an outlet with an exposed height between 0 and 1 mm, said outlet being inserted into the skin to a depth of between 0.3 mm and 2 mm, such that delivery of the substance occurs at a depth between 0.3 mm and 2 mm and a microneedle for intradermal injection of a high molecular weight pharmaceutical substance, wherein the microneedle has a length and outlet selected for its suitability for specifically delivering the substance into the dermis.
  • U.S. Pat. No. 5,527,288 discloses an intradermal drug delivery device for delivering a liquid drug to a subject via the subject's skin, comprising a housing having a lower surface for application to the skin of the subject; means for affixing the housing in position with the lower surface in contact with the subject's skin; and a drug reservoir within the housing.
  • the reservoir is in the form of an expansible-contractible chamber which is expanded when filled with the drug and which can be contracted to dispense the drug therefrom.
  • a single hollow needle is associated with the drug reservoir and extends through the lower surface, having an inner end communicating with the drug reservoir and an outer end projecting outwards a sufficient distance so as to penetrate through the epidermis and into the dermis when the housing is pressed against the skin.
  • the device also includes means for actively discharging the drug from the reservoir to the subject's skin via the needle.
  • U.S. Pat. No. 6,689,118 is directed to a method of making an intradermal injection into the skin of an animal to obtain systemic delivery or to induce an immune response.
  • the method comprises providing a drug delivery device including a needle cannula having a forward needle tip and a needle cannula being in fluid communication with a substance contained in said drug delivery device; inserting the needle tip into the skin of an animal and engaging the surface of the skin with a skin engaging surface of a limiter portion such that the skin engaging surface of the limiter portion limits penetration of the needle Up into the dermis layer of the skin of the animal; and expelling the substance from the drug deliver device through the needle tip into the skin of the animal to expose the injected substance to the microcirculatory blood vasculature and the lymphatic plexuses.
  • U.S. Pat. No. 6,569,143 is directed to another related method of making an intradermal injection comprising providing a drug delivery device; inserting a needle tip into the skin of an animal whereby penetration of the needle Up is limited to the dermis layer of the skin of the animal; and expelling the substance from said drug delivery device through the needle tip into the skin of the animal.
  • U.S. Pat. No. 5,997,501 describes an intradermal drug delivery device for the delivery of at least one drug to a subject via the subject's skin.
  • the device comprises a housing having a lower surface; a drug reservoir located with the housing; a cover that is adjustable engaged with the housing from a first extended position to a second retracted position such that the cover is proximal to the lower surface of the housing when the cover is retracted and the cover is distal to the lower surface of the housing when the cover is extended; means for affixing the cover in position with the lower surface of the housing in contact with the subject's skin; a single hollow needle fixed to the cover and having a first end in communication with the drug reservoir and a second end projecting outwards no further than the lower surface of the housing when the cover is extended, and to penetrate through the epidermis and into the dermis when the cover is retracted; and means for actively discharging the drug from the reservoir to the subject's skin via the needle.
  • the device of the present invention is based on a unique technology that allows a liquid pharmaceutical formulation to be delivered into the skin of the patients through a fine needle without the significant pain experienced by regular injection needles.
  • the drug is injected into the layers of the skin, avoiding the pinching of the nerves. This reduces pain significantly or eliminates it totally in many cases thus improving the acceptance and compliance to treat many diseases like diabetes.
  • the present invention addresses the problems of the prior art by providing a novel type of reservoir for a drug and a delivery device for delivering the drug from the reservoir to a specific depth of skin.
  • a method of preparing the drug reservoir and a method of delivering a fluid drug are also provided.
  • a reservoir for carrying an active agent comprises a fillable bladder having flexible walls that can be sealed.
  • a method of manufacturing such a reservoir comprises the steps of: opposing two layers of thermoplastic film; heating the film; applying a vacuum mold to the outer surface of each layer of film to form a bubble; and allowing the film to cool.
  • the method comprises preparing a sheet of thermoplastic material having a series of wells or depressions as fillable reservoirs. A top sheet is then applied to seal the reservoirs.
  • a method of filling the reservoir comprises filling the bladder with a fluid drug; and sealing the reservoir.
  • a device for delivery of a fluid drug to an animal comprising a housing having an upper end and a lower end, the lower end having an aperture therein and the upper end being adapted to receive a drive actuator.
  • a reservoir chamber is disposed within the housing and operatively linked to the drive actuator.
  • the reservoir chamber has a base and wall(s). The wall may be a continuous circular wall or a connected set of walls.
  • Within the reservoir chamber there is a flexible reservoir filled with the fluid drug.
  • a microneedle is mounted on the base so as to transverse the base of the chamber such that the top of the needle is in communication with the chamber and the tip of the needle extends in the housing below the chamber.
  • the reservoir chamber is located at a predetermined distance from the lower end of the housing whereby abutment of the base of the chamber to the lower end of the housing acts as a stop to provide a predetermined length of travel of the needle through the aperture when the drive mechanism or actuator is activated.
  • the length of travel is optimally set to deliver the drug intradermally.
  • the device also preferably includes biasing means to maintain the reservoir chamber in the upper position within the housing, in the absence of pressure on the actuator thus retaining the needle tip inside the housing.
  • the device in another embodiment, includes a lower housing and an upper housing that fits over the lower housing.
  • the upper housing is continuous with the actuator that causes the reservoir to descend and contact the needle end.
  • a method of administering a fluid drug through the skin of an animal comprises providing a device as defined above; applying the lower surface of the device to the skin; exerting pressure on the drive mechanism thereby lowering the reservoir chamber and causing the needle tip to travel through the aperture and into the skin a predetermined distance; and applying continued pressure on the actuator to cause the upper end of the needle to pierce the reservoir and continuing to apply pressure so that all the contents of the reservoir flow through the needle into the skin.
  • FIGS. 1A to 1 G illustrate the steps in the manufacture of a drug reservoir according to the present invention
  • FIGS. 2A to 2 J Illustrate the operation of one embodiment of a delivery device of the invention
  • FIGS. 3A and 3B illustrate another embodiment of a delivery device
  • FIGS. 4A to 4 C illustrate yet another embodiment of a delivery device.
  • a novel type of drug reservoir comprises a fillable bladder.
  • the reservoir is formed between two layers of plastic film.
  • the two layers can be formed from two sheets or from one sheet folded in half. When two sheets are used, the sheets may comprise the same material, thickness, etc. or they may be two different types of sheets.
  • the present invention provides for a drug delivery device incorporating a disposable reservoir.
  • the device may be provided as a single-use, disposable device or a multi-use device.
  • the device comprises a housing that has an upper end and a lower end.
  • the term “upper” is used to refer to the surface furthest away from an individual skin and the term “lower” is used to refer to the part of the device that contacts a patient's skin.
  • An actuator is mounted at the top of the housing.
  • the actuator is used to activate a drive mechanism.
  • One example of a drive mechanism is a plunger that travels up and down within the housing.
  • a reservoir chamber is slideably mounted within the housing.
  • the reservoir chamber holds a reservoir filled with a liquid.
  • the reservoir chamber is operatively linked to the drive mechanism.
  • the reservoir chamber has a micro needle mounted on the lower surface of the chamber.
  • FIGS. 1 A-G A process for the manufacture of one embodiment of the reservoir is shown in FIGS. 1 A-G.
  • a sheet of thermoplastic material 10 is folded in half to provide a first surface 12 and a second surface 14 .
  • the sheet 10 is folded so that the first surface and the second surface overlap each other. Then the sheet is heated to soften the film.
  • FIG. 1C illustrates a mold 18 applied to each of the surfaces 12 , 14 .
  • the mold for each side may be of similar or different shapes.
  • a vacuum is applied to the mold halves, a bubble 20 is formed and at the same time the boundary 22 of the reservoir shape is sealed.
  • a vertical path 24 is left open for filling of the reservoir. As shown in FIG.
  • FIG. 1D the mold halves 18 are removed and the sheet 10 including the bubbles 20 are cooled to room temperature.
  • the filling process is demonstrated in FIG. 1E .
  • the film is preferably oriented with the vertical path 24 open at the top for filling to avoid the formation of air pockets during the filling process.
  • a fine dispensing nozzle 26 is inserted into the vertical path 24 and a controlled amount of drug 27 is inserted into the reservoir.
  • the open end 30 of the vertical path 24 is then heat sealed as shown in FIG. 1F .
  • the bubble shaped reservoir 20 can then be trimmed as shown in FIG. 1G from the remaining sheets of plastic film or the bubble shapes can be partially trimmed and the bubbles can be stored in a roll format.
  • the reservoir is formed by preparing a sheet of material having a series of wells or depressions. The wells are filled with a drug and then an upper sheet is applied to cover and seal the open end of the wells.
  • the reservoir comprises a fillable, sealable bladder of thermoplastic material.
  • a round, blue bubble may indicate that the reservoir contains insulin and a square pink bubble may indicate a DPT vaccine.
  • the reservoir of the present invention can be used to store many different kinds of active agents. Color coding can be used to identify the agent and/or dose strength.
  • the present invention also provides a device and method for delivery of the drug stored in the reservoir to an animal, preferably a human.
  • the device comprises an outer housing.
  • the outer housing can be made of any durable material, preferably a hard plastic.
  • the outer housing can take various shapes, e.g. it can be round, oval, hexagonal, square etc.
  • the outer housing can incorporate various colours to identify the agent and/or dose strength.
  • the outer housing defines an internal chamber that includes an open top at the upper end and a base having an aperture at the lower end.
  • a reservoir chamber is fitted inside the housing.
  • the reservoir chamber is adapted to receive a disposable reservoir such as that described above.
  • a microneedle is mounted in the bottom platform of the reservoir chamber with its upper (non-skin contacting) end protruding upward and just below the reservoir and the skin-contacting tip extending beyond the bottom of the chamber.
  • the reservoir chamber frictionally engages the internal wall(s) of the housing.
  • a drug reservoir or bubble is contained within the reservoir chamber.
  • a drive actuator is operatively linked to the reservoir chamber.
  • the drive actuator may include a flexible dome or an upper casing.
  • the reservoir chamber typically comprises an open upper end, an internal chamber to hold the reservoir and a base platform with the needle mounted so that it transects the base.
  • a retraction mechanism such as a vacuum bulb or a spring is also optionally included.
  • the delivery device is placed on the skin with the lower end of the housing touching the skin.
  • the drive mechanism is then actuated to drive the reservoir chamber downwards until the base platform of the reservoir chamber hits the base of the housing. This causes the needle to exit through the aperture in the base of the housing a predetermined distance and enter into the skin to a predetermined depth. Further downward pressure on the plunger compresses the drug filled reservoir and causes it to be pierced by the upper end of the needle.
  • retraction means cause the needle to be retracted back into the housing for disposal.
  • the device 50 comprises housing 52 .
  • the housing has an open upper end 54 and a bottom base 56 defining an interior chamber 58 that optionally includes a spring.
  • the bottom base comprises an aperture 60 .
  • the interior of the housing is adapted to receive a reservoir chamber 62 .
  • the reservoir chamber comprises a base 64 and a surrounding wall 66 extending upwards from the base defining a chamber 62 with an open top 68 .
  • a filled reservoir body 70 is located in the reservoir chamber.
  • a single hollow needle 72 is associated with the reservoir chamber 62 .
  • the needle 72 extends through the base 64 of the chamber 62 and has a cannula with an upper end 74 communicating with the interior 75 of the reservoir chamber and a lower end 78 projecting out of the chamber and down a predetermined distance.
  • the open top 68 of the reservoir chamber is adapted to receive an actuator 80 .
  • the actuator comprises a plunger 82 having an activation flange 84 at one end and a stopper 86 at the other end. In the initial position of the device as provided and as shown in FIGS.
  • the base 64 of the reservoir chamber 62 is held at a predetermined distance from the interior surface 88 of the base 56 of the housing by at least one releasable latch 90 which retains the chamber in position by the interaction of the latch 90 with a latch retainer 92 .
  • the latch 90 includes a notch 91 .
  • an upper housing 96 encases the plunger 80 .
  • the distance the needle travels can be varied depending on the desired application and on the bubble position and the length of the needle.
  • the device can be adapted to have the needle travel a distance between about 0.5 mm to about 10 mm.
  • the device of the invention can be adapted for intradermal, subcutaneous or intramuscular injections.
  • the needle preferably travels from about 3 mm to 8 mm.
  • the needle gauge is preferably 25 to 84 gauge although different gauge needles can be used.
  • FIGS. 2A and 28 illustrate the device in the initial state as described above.
  • the base 56 of the housing 52 is placed against the skin.
  • the latch 90 is released from the retainer 92 .
  • the actuator 80 is connected to the reservoir chamber 62 via a notch 100 and tab 102 connector and the reservoir chamber will be forced down until the base 64 of the reservoir chamber 62 hits the interior surface 88 of the housing base 56 and the chamber is stopped from any further downward movement.
  • the distance that the needle extends is about 0.5 to 10 mm, preferably 0.5 to 5 mm, more preferably from about 3 mm to about 5 mm, even more preferably from about 1.5 to 3 mm.
  • the outer layer of skin, the epidermis typically has a thickness of about 0.5 to 2 mm.
  • the inner layer, the dermis has a thickness of about 1.5 to 3 mm.
  • the dermis comprises two layers, the papillary layer and the reticular layer.
  • the reticular layer contains many blood vessels and lymph vessels, making it a desirable area for delivery of active agents. Below the dermis is the subcutaneous layer and then muscle.
  • the distance that the tip of the needle can extend beyond the lower outer surface of the housing is selected to be optimum for insertion in the dermis or subcutaneous layer.
  • the lower tip of the needle 78 exits the aperture 60 .
  • the downward travel of the reservoir chamber 62 is limited when the base 64 of the chamber contacts the base 56 of the housing. In this way the travel of the needle through the aperture 60 is also limited so as to limit the depth of penetration of the needle into the skin.
  • the components of the device have been configured so that the distance that the bottom of the chamber travels is translated into a predetermined travel for the needle through the aperture in the bottom of the housing to provide a certain skin penetration.
  • the tab 102 is released from the notch 100 and the plunger 82 descends within the reservoir chamber forcing the filled reservoir 70 downwards until it contacts the base 64 of the reservoir chamber 62 .
  • the actuator 80 exerts pressure on the reservoir 70 , the reservoir 70 contacts the upper end 74 of the needle 72 and is punctured.
  • the cannula of the needle 72 is now in fluid communication with the contents of the reservoir.
  • the needle is preferably retracted back into the housing 52 as illustrated in FIGS. 2I and 2J .
  • the position of the reservoir chamber 62 carrying the needle 72 is preferably biased to the pre-activation position by biasing means such as a spring, a vacuum bulb or a moldable bulb.
  • biasing means such as a spring, a vacuum bulb or a moldable bulb.
  • the base 64 of the reservoir chamber moves up in the housing thus automatically retracting the used needle into the housing. This provides for safe disposal of the device.
  • the needle is preferably locked in the retracted position.
  • FIG. 2J shows a retracted reservoir chamber that is locked in position when tab 102 slides into indent 104 .
  • an actuator 106 is continuous with an upper casing 108 that fits over a housing 110 .
  • the housing 110 receives a reservoir chamber 112 that has a needle 114 transversely mounted through its base 116 .
  • a drug reservoir 118 is contained within the chamber 112 .
  • pressure on the actuator 106 causes the reservoir chamber 112 to descend until it abuts the base 120 of the housing 110 .
  • the chamber 112 descends, it drives the tip 122 of the needle 114 through an aperture 124 in the housing 110 . Further pressure causes the rear 126 of the needle to puncture the reservoir 118 .
  • the contents of the reservoir are expelled through the needle.
  • a flexible dome fits over the plunger rod and activation flange. It is also clearly apparent the manual activation flange can be exposed.
  • the device also optionally includes a spring that is located around or below the reservoir chamber base such that when pressure on the activation flange is released the compressive energy of the spring causes the needle to be retracted back into the housing.
  • FIGS. 4A to 4 C illustrate another embodiment of the device.
  • the device 130 includes a housing 132 and an upper casing 134 .
  • An actuator 136 is operably linked to a reservoir chamber 138 disposed within the housing 132 .
  • a drug filled reservoir 140 is placed in the reservoir chamber 138 .
  • a needle 142 is mounted so as to transverse the base 144 of the chamber 138 .
  • the device also includes a spring 146 that biases the reservoir chamber 138 upwards in the housing 132 .
  • the actuator 136 compresses and the reservoir chamber travels downward carrying the needle and the needle tip 148 exits the housing 132 .
  • the actuator 136 compresses the drug filled reservoir 140 until the back 150 of the needle punctures the reservoir and the contents flow through the needle as shown in FIG. 4C .
  • a method for delivering an effective amount of a liquid active agent to an animal preferably a human.
  • the method comprises providing a drug delivery device according to the present invention, said device containing a reservoir filled with the desired drug; applying the bottom surface of the drug delivery device of the invention to the skin of an animal, applying pressure on the actuator to cause the needle to enter the skin, applying continued pressure to puncture the reservoir and deliver the contents of the reservoir through the cannula of the needle.
  • the device of the present invention can be used to deliver a variety of active agents.
  • drug is used loosely herein to refer to prophylactic as well as therapeutic agents.
  • vaccines may be delivered using the device.
  • active agents such as nucleic acids, small molecules, therapeutic proteins, hormones, analgesics, etc. in additional to traditional pharmacologic agents.
  • Typical drugs include peptides, proteins or hormones such as insulin, calcitonin, calcitonin gene regulating protein, atrial natriuretic protein, colony stimulating factor, betaseton, erythropoietin (EPO), interferons such as ⁇ , ⁇ , or ⁇ interferon, somatropin, somatotropin, somatostatin, insulin-like growth factor (somatomedins), luteinizing hormone releasing hormone (LHRH), tissue plasminogen activator (TPA), growth hormone release hormone (GHRH), oxytocin, estradiol, growth hormones, leuprolide acetate, factor VIII, interleukins such as interleukin-2, and analogues thereof; analgesics such as fentanyl, sufentanil, butorphanol, buprenorphine, levorphanol, morphine, hydromorphone, hydrocodone, oxymorephone, methadone, lidoca
  • fluid refers to any fluid containing an active agent or communication of agents that can pass through the cannula of the microneedle. This includes a liquid, a solution, a gel, a dispersion or a fine suspension.

Abstract

A novel device and method for intradermal delivery of an active agent is provided. The device comprises a housing which contains a reservoir chamber. A flexible reservoir containing the active agent is placed in the chamber. Upon pressure on an actuator the active agents is delivered via a hollow needle to the skin.

Description

    FIELD OF INVENTION
  • The present invention relates to drug delivery devices and methods of delivering a drug intradermally. In particular, the present invention relates to intradermal delivery of a liquid drug.
  • BACKGROUND OF THE INVENTION
  • There has long been a desire to deliver drugs intradermally. The skin comprises two layers, the outer or upper surface called the epidermis, and the internal surface referred to as the dermis. The epidermis does not contain any blood vessels and it is dependent on the underlying dermis for nutrient delivery and waste disposal via diffusion. The inner layer, the dermis, is composed of two layers, the more superficial papillary dermis and the deeper reticular dermis. The papillary dermis is thinner and consists primarily of loose connective tissue containing small capillaries, elastic fibers, reticular fibers and some collagen. The deeper reticular dermis consists of a thicker connective tissue containing larger blood vessels, interlaced elastic fibers and core spindles of collagen fibers arranged in layers parallel to the surface. The reticular layer also contains many antigen-presenting cells, fibroblasts, mast cells, nerve endings, and lymphatics. Because of the high amount of blood vessels, lymphatics and antigen presenting cells in the dermis, this is an ideal site for delivery of drugs and/or antigens.
  • A major problem, however, with intradermal delivery is the difficulty in precisely delivering the drug into the dermal layer. Generally, the outer layer, the epidermis, has a thickness of about 0.05 to 2 mm and the dermis has a thickness between about 1.5 and 4 mm. Thus, to deliver an agent to the dermis, the needle must penetrate the skin to a depth of no more than 5 mm, preferably between about 2 and 4 mm. It is very difficult to control an injection to this shallow depth. For certain types of injection, such as the Mantoux test for tuberculosis, a fine gauge needle is inserted at a 45° angle to try and get the agent into the dermis.
  • Several efforts have been made to try and find reliable ways of delivering agents to the dermis. For example, United States Patent Application No. 2005/0124967 is directed to a method for directly delivering a high molecular weight substance into an intradermal space within mammalian skin comprising administering the substance through at lease one hollow needle having an outlet with an exposed height between 0 and 1 mm, said outlet being inserted into the skin to a depth of between 0.3 mm and 2 mm, such that delivery of the substance occurs at a depth between 0.3 mm and 2 mm and a microneedle for intradermal injection of a high molecular weight pharmaceutical substance, wherein the microneedle has a length and outlet selected for its suitability for specifically delivering the substance into the dermis.
  • U.S. Pat. No. 5,527,288 discloses an intradermal drug delivery device for delivering a liquid drug to a subject via the subject's skin, comprising a housing having a lower surface for application to the skin of the subject; means for affixing the housing in position with the lower surface in contact with the subject's skin; and a drug reservoir within the housing. The reservoir is in the form of an expansible-contractible chamber which is expanded when filled with the drug and which can be contracted to dispense the drug therefrom. A single hollow needle is associated with the drug reservoir and extends through the lower surface, having an inner end communicating with the drug reservoir and an outer end projecting outwards a sufficient distance so as to penetrate through the epidermis and into the dermis when the housing is pressed against the skin. The device also includes means for actively discharging the drug from the reservoir to the subject's skin via the needle.
  • U.S. Pat. No. 6,689,118 is directed to a method of making an intradermal injection into the skin of an animal to obtain systemic delivery or to induce an immune response. The method comprises providing a drug delivery device including a needle cannula having a forward needle tip and a needle cannula being in fluid communication with a substance contained in said drug delivery device; inserting the needle tip into the skin of an animal and engaging the surface of the skin with a skin engaging surface of a limiter portion such that the skin engaging surface of the limiter portion limits penetration of the needle Up into the dermis layer of the skin of the animal; and expelling the substance from the drug deliver device through the needle tip into the skin of the animal to expose the injected substance to the microcirculatory blood vasculature and the lymphatic plexuses.
  • U.S. Pat. No. 6,569,143 is directed to another related method of making an intradermal injection comprising providing a drug delivery device; inserting a needle tip into the skin of an animal whereby penetration of the needle Up is limited to the dermis layer of the skin of the animal; and expelling the substance from said drug delivery device through the needle tip into the skin of the animal.
  • U.S. Pat. No. 5,997,501 describes an intradermal drug delivery device for the delivery of at least one drug to a subject via the subject's skin. The device comprises a housing having a lower surface; a drug reservoir located with the housing; a cover that is adjustable engaged with the housing from a first extended position to a second retracted position such that the cover is proximal to the lower surface of the housing when the cover is retracted and the cover is distal to the lower surface of the housing when the cover is extended; means for affixing the cover in position with the lower surface of the housing in contact with the subject's skin; a single hollow needle fixed to the cover and having a first end in communication with the drug reservoir and a second end projecting outwards no further than the lower surface of the housing when the cover is extended, and to penetrate through the epidermis and into the dermis when the cover is retracted; and means for actively discharging the drug from the reservoir to the subject's skin via the needle.
  • Although multiple efforts have been made to try and provide a device for intradermal delivery, many of the prior art devices are expensive to manufacture or can only be used for one drug. In spite of all the efforts made to provide a method and/or device for intradermal delivery, there remained a need for a reliable, single-use, disposable device for intradermal delivery.
  • SUMMARY OF THE INVENTION
  • Many people consider an injection (at best) unpleasant and (at worst) a painful encounter, no matter how well the nurse or doctor administers the shot This is because most shots are given subcutaneously or intramuscularly, reaching deep enough into the skin to hit nerves. Part of the skin's job is to sense danger in the environment through nerve cells, and it is richly endowed with these cells—a single square inch of skin contains approximately 1,300 nerve endings. Since most injections are given subcutaneously or intramuscularly, thereby delivering drugs to be absorbed into the blood vessels, the needle generally strikes nerves and causes pain along the way. The device of the present invention is based on a unique technology that allows a liquid pharmaceutical formulation to be delivered into the skin of the patients through a fine needle without the significant pain experienced by regular injection needles. The drug is injected into the layers of the skin, avoiding the pinching of the nerves. This reduces pain significantly or eliminates it totally in many cases thus improving the acceptance and compliance to treat many diseases like diabetes.
  • The present invention addresses the problems of the prior art by providing a novel type of reservoir for a drug and a delivery device for delivering the drug from the reservoir to a specific depth of skin. A method of preparing the drug reservoir and a method of delivering a fluid drug are also provided.
  • In one aspect of the invention a reservoir for carrying an active agent is provided. The reservoir comprises a fillable bladder having flexible walls that can be sealed.
  • A method of manufacturing such a reservoir is also provided. In one embodiment, the method comprises the steps of: opposing two layers of thermoplastic film; heating the film; applying a vacuum mold to the outer surface of each layer of film to form a bubble; and allowing the film to cool.
  • In another embodiment, the method comprises preparing a sheet of thermoplastic material having a series of wells or depressions as fillable reservoirs. A top sheet is then applied to seal the reservoirs.
  • A method of filling the reservoir is also provided and comprises filling the bladder with a fluid drug; and sealing the reservoir.
  • In another aspect of the invention, a device for delivery of a fluid drug to an animal is provided. The term “animal” is used herein to include both human and non-human animals. The devices and methods of the invention are applicable for both human and veterinary use. The device comprises a housing having an upper end and a lower end, the lower end having an aperture therein and the upper end being adapted to receive a drive actuator. A reservoir chamber is disposed within the housing and operatively linked to the drive actuator. The reservoir chamber has a base and wall(s). The wall may be a continuous circular wall or a connected set of walls. Within the reservoir chamber, there is a flexible reservoir filled with the fluid drug. A microneedle is mounted on the base so as to transverse the base of the chamber such that the top of the needle is in communication with the chamber and the tip of the needle extends in the housing below the chamber.
  • In a preferred embodiment, the reservoir chamber is located at a predetermined distance from the lower end of the housing whereby abutment of the base of the chamber to the lower end of the housing acts as a stop to provide a predetermined length of travel of the needle through the aperture when the drive mechanism or actuator is activated. The length of travel is optimally set to deliver the drug intradermally. The device also preferably includes biasing means to maintain the reservoir chamber in the upper position within the housing, in the absence of pressure on the actuator thus retaining the needle tip inside the housing.
  • In another embodiment of the invention, the device includes a lower housing and an upper housing that fits over the lower housing. In this embodiment, the upper housing is continuous with the actuator that causes the reservoir to descend and contact the needle end.
  • In yet another aspect of the invention, a method of administering a fluid drug through the skin of an animal is provided. The method comprises providing a device as defined above; applying the lower surface of the device to the skin; exerting pressure on the drive mechanism thereby lowering the reservoir chamber and causing the needle tip to travel through the aperture and into the skin a predetermined distance; and applying continued pressure on the actuator to cause the upper end of the needle to pierce the reservoir and continuing to apply pressure so that all the contents of the reservoir flow through the needle into the skin.
  • This summary of the invention does not necessarily describe all features of the invention.
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • These and other features of the invention will become more apparent from the following description in which reference is made to the appended drawings wherein:
  • FIGS. 1A to 1G illustrate the steps in the manufacture of a drug reservoir according to the present invention;
  • FIGS. 2A to 2J Illustrate the operation of one embodiment of a delivery device of the invention;
  • FIGS. 3A and 3B illustrate another embodiment of a delivery device; and;
  • FIGS. 4A to 4C illustrate yet another embodiment of a delivery device.
  • DETAILED DESCRIPTION
  • The following description is of preferred embodiments.
  • In one aspect of the present invention a novel type of drug reservoir is provided. The drug reservoir comprises a fillable bladder. The reservoir is formed between two layers of plastic film. The two layers can be formed from two sheets or from one sheet folded in half. When two sheets are used, the sheets may comprise the same material, thickness, etc. or they may be two different types of sheets.
  • The present invention provides for a drug delivery device incorporating a disposable reservoir. The device may be provided as a single-use, disposable device or a multi-use device. The device comprises a housing that has an upper end and a lower end. As used herein, the term “upper” is used to refer to the surface furthest away from an individual skin and the term “lower” is used to refer to the part of the device that contacts a patient's skin. An actuator is mounted at the top of the housing. The actuator is used to activate a drive mechanism. One example of a drive mechanism is a plunger that travels up and down within the housing. A reservoir chamber is slideably mounted within the housing. The reservoir chamber holds a reservoir filled with a liquid. The reservoir chamber is operatively linked to the drive mechanism. The reservoir chamber has a micro needle mounted on the lower surface of the chamber. When the plunger is depressed, the reservoir housing travels downward within the housing until it stops when the bottom of the reservoir housing hits the bottom of the outer housing.
  • A process for the manufacture of one embodiment of the reservoir is shown in FIGS. 1A-G. In FIG. 1A, a sheet of thermoplastic material 10 is folded in half to provide a first surface 12 and a second surface 14. Referring to FIG. 1B, the sheet 10 is folded so that the first surface and the second surface overlap each other. Then the sheet is heated to soften the film. FIG. 1C illustrates a mold 18 applied to each of the surfaces 12, 14. The mold for each side may be of similar or different shapes. As a vacuum is applied to the mold halves, a bubble 20 is formed and at the same time the boundary 22 of the reservoir shape is sealed. A vertical path 24 is left open for filling of the reservoir. As shown in FIG. 1D, the mold halves 18 are removed and the sheet 10 including the bubbles 20 are cooled to room temperature. The filling process is demonstrated in FIG. 1E. The film is preferably oriented with the vertical path 24 open at the top for filling to avoid the formation of air pockets during the filling process. A fine dispensing nozzle 26 is inserted into the vertical path 24 and a controlled amount of drug 27 is inserted into the reservoir. The open end 30 of the vertical path 24 is then heat sealed as shown in FIG. 1F. The bubble shaped reservoir 20 can then be trimmed as shown in FIG. 1G from the remaining sheets of plastic film or the bubble shapes can be partially trimmed and the bubbles can be stored in a roll format.
  • In another embodiment, the reservoir is formed by preparing a sheet of material having a series of wells or depressions. The wells are filled with a drug and then an upper sheet is applied to cover and seal the open end of the wells. In both embodiments the reservoir comprises a fillable, sealable bladder of thermoplastic material.
  • Various colors and shapes of reservoirs can be used for different drugs. For example, a round, blue bubble may indicate that the reservoir contains insulin and a square pink bubble may indicate a DPT vaccine. The reservoir of the present invention can be used to store many different kinds of active agents. Color coding can be used to identify the agent and/or dose strength.
  • The present invention also provides a device and method for delivery of the drug stored in the reservoir to an animal, preferably a human. The device comprises an outer housing. The outer housing can be made of any durable material, preferably a hard plastic. The outer housing can take various shapes, e.g. it can be round, oval, hexagonal, square etc. The outer housing can incorporate various colours to identify the agent and/or dose strength. The outer housing defines an internal chamber that includes an open top at the upper end and a base having an aperture at the lower end. A reservoir chamber is fitted inside the housing. The reservoir chamber is adapted to receive a disposable reservoir such as that described above. A microneedle is mounted in the bottom platform of the reservoir chamber with its upper (non-skin contacting) end protruding upward and just below the reservoir and the skin-contacting tip extending beyond the bottom of the chamber. The reservoir chamber frictionally engages the internal wall(s) of the housing. A drug reservoir or bubble is contained within the reservoir chamber. A drive actuator is operatively linked to the reservoir chamber. The drive actuator may include a flexible dome or an upper casing. The reservoir chamber typically comprises an open upper end, an internal chamber to hold the reservoir and a base platform with the needle mounted so that it transects the base. A retraction mechanism such as a vacuum bulb or a spring is also optionally included.
  • In use, the delivery device is placed on the skin with the lower end of the housing touching the skin. The drive mechanism is then actuated to drive the reservoir chamber downwards until the base platform of the reservoir chamber hits the base of the housing. This causes the needle to exit through the aperture in the base of the housing a predetermined distance and enter into the skin to a predetermined depth. Further downward pressure on the plunger compresses the drug filled reservoir and causes it to be pierced by the upper end of the needle. This puts the cannula of the needle in fluid communication with the contents of the reservoir and as the downward pressure continues until the tip of the plunger bottoms on the base platform of the reservoir chamber, the contents of the reservoir are passed through the cannula of the needle to the skin of an animal or human subject. When the pressure on the drive mechanism is released, retraction means cause the needle to be retracted back into the housing for disposal.
  • One preferred embodiment of the device and its operation is shown in FIGS. 2A-J. The device 50 comprises housing 52. The housing has an open upper end 54 and a bottom base 56 defining an interior chamber 58 that optionally includes a spring. The bottom base comprises an aperture 60. The interior of the housing is adapted to receive a reservoir chamber 62. The reservoir chamber comprises a base 64 and a surrounding wall 66 extending upwards from the base defining a chamber 62 with an open top 68. A filled reservoir body 70 is located in the reservoir chamber.
  • A single hollow needle 72 is associated with the reservoir chamber 62. The needle 72 extends through the base 64 of the chamber 62 and has a cannula with an upper end 74 communicating with the interior 75 of the reservoir chamber and a lower end 78 projecting out of the chamber and down a predetermined distance. The open top 68 of the reservoir chamber is adapted to receive an actuator 80. In the illustrated embodiment, the actuator comprises a plunger 82 having an activation flange 84 at one end and a stopper 86 at the other end. In the initial position of the device as provided and as shown in FIGS. 2A and 2B, the base 64 of the reservoir chamber 62 is held at a predetermined distance from the interior surface 88 of the base 56 of the housing by at least one releasable latch 90 which retains the chamber in position by the interaction of the latch 90 with a latch retainer 92. The latch 90 includes a notch 91.
  • In one preferred embodiment an upper housing 96 encases the plunger 80.
  • It is clearly apparent that the distance the needle travels can be varied depending on the desired application and on the bubble position and the length of the needle. For example, the device can be adapted to have the needle travel a distance between about 0.5 mm to about 10 mm. Thus, the device of the invention can be adapted for intradermal, subcutaneous or intramuscular injections. The needle preferably travels from about 3 mm to 8 mm. The needle gauge is preferably 25 to 84 gauge although different gauge needles can be used.
  • The operation of the device is illustrated sequentially in FIGS. 2A to 2J. FIGS. 2A and 28 illustrate the device in the initial state as described above. Referring now to FIGS. 2C and 2D for use, the base 56 of the housing 52 is placed against the skin. When pressure is exerted on the actuator 80, the latch 90 is released from the retainer 92. The actuator 80 is connected to the reservoir chamber 62 via a notch 100 and tab 102 connector and the reservoir chamber will be forced down until the base 64 of the reservoir chamber 62 hits the interior surface 88 of the housing base 56 and the chamber is stopped from any further downward movement. By adjusting the relative sizes and positions of the components, the length of the travel of the needle through the aperture into the skin can be tightly controlled. The distance that the needle extends is about 0.5 to 10 mm, preferably 0.5 to 5 mm, more preferably from about 3 mm to about 5 mm, even more preferably from about 1.5 to 3 mm. The outer layer of skin, the epidermis typically has a thickness of about 0.5 to 2 mm. and the inner layer, the dermis, has a thickness of about 1.5 to 3 mm. The dermis comprises two layers, the papillary layer and the reticular layer. The reticular layer contains many blood vessels and lymph vessels, making it a desirable area for delivery of active agents. Below the dermis is the subcutaneous layer and then muscle. In a preferred embodiment, the distance that the tip of the needle can extend beyond the lower outer surface of the housing is selected to be optimum for insertion in the dermis or subcutaneous layer. As the reservoir chamber 62, carrying the needle 72 descends, the lower tip of the needle 78 exits the aperture 60. The downward travel of the reservoir chamber 62 is limited when the base 64 of the chamber contacts the base 56 of the housing. In this way the travel of the needle through the aperture 60 is also limited so as to limit the depth of penetration of the needle into the skin. The components of the device have been configured so that the distance that the bottom of the chamber travels is translated into a predetermined travel for the needle through the aperture in the bottom of the housing to provide a certain skin penetration.
  • Referring now to FIGS. 2E and 2F, as continued pressure is applied to the actuator 80, the tab 102 is released from the notch 100 and the plunger 82 descends within the reservoir chamber forcing the filled reservoir 70 downwards until it contacts the base 64 of the reservoir chamber 62. As the actuator 80 exerts pressure on the reservoir 70, the reservoir 70 contacts the upper end 74 of the needle 72 and is punctured. The cannula of the needle 72 is now in fluid communication with the contents of the reservoir.
  • Referring now to FIGS. 2G and 2H, continued pressure on the actuator 80 compresses the reservoir 70 and forces all the contents to flow through the needle 72 and into the patient. The downward travel of the actuator 80 is stopped when the plunger stopper 86 contacts the base 64 of the reservoir chamber 62.
  • After use, the needle is preferably retracted back into the housing 52 as illustrated in FIGS. 2I and 2J. The position of the reservoir chamber 62 carrying the needle 72 is preferably biased to the pre-activation position by biasing means such as a spring, a vacuum bulb or a moldable bulb. Once pressure is released on the actuator 80, the base 64 of the reservoir chamber moves up in the housing thus automatically retracting the used needle into the housing. This provides for safe disposal of the device. In a preferred embodiment, the needle is preferably locked in the retracted position. FIG. 2J shows a retracted reservoir chamber that is locked in position when tab 102 slides into indent 104.
  • In the embodiment illustrated in FIGS. 3A and 3B, an actuator 106 is continuous with an upper casing 108 that fits over a housing 110. The housing 110 receives a reservoir chamber 112 that has a needle 114 transversely mounted through its base 116. A drug reservoir 118 is contained within the chamber 112. As shown in FIG. 3B, pressure on the actuator 106 causes the reservoir chamber 112 to descend until it abuts the base 120 of the housing 110. As the chamber 112 descends, it drives the tip 122 of the needle 114 through an aperture 124 in the housing 110. Further pressure causes the rear 126 of the needle to puncture the reservoir 118. Upon continued pressure, the contents of the reservoir are expelled through the needle.
  • In another embodiment, a flexible dome fits over the plunger rod and activation flange. It is also clearly apparent the manual activation flange can be exposed. The device also optionally includes a spring that is located around or below the reservoir chamber base such that when pressure on the activation flange is released the compressive energy of the spring causes the needle to be retracted back into the housing.
  • FIGS. 4A to 4C illustrate another embodiment of the device. The device 130 includes a housing 132 and an upper casing 134. An actuator 136 is operably linked to a reservoir chamber 138 disposed within the housing 132. For use, a drug filled reservoir 140 is placed in the reservoir chamber 138. A needle 142 is mounted so as to transverse the base 144 of the chamber 138. The device also includes a spring 146 that biases the reservoir chamber 138 upwards in the housing 132. Upon pressure on the actuator 136, the spring compresses and the reservoir chamber travels downward carrying the needle and the needle tip 148 exits the housing 132. Upon further pressure, the actuator 136 compresses the drug filled reservoir 140 until the back 150 of the needle punctures the reservoir and the contents flow through the needle as shown in FIG. 4C.
  • In another aspect of the invention, a method for delivering an effective amount of a liquid active agent to an animal, preferably a human, is provided. The method comprises providing a drug delivery device according to the present invention, said device containing a reservoir filled with the desired drug; applying the bottom surface of the drug delivery device of the invention to the skin of an animal, applying pressure on the actuator to cause the needle to enter the skin, applying continued pressure to puncture the reservoir and deliver the contents of the reservoir through the cannula of the needle.
  • The device of the present invention can be used to deliver a variety of active agents. The term “drug” is used loosely herein to refer to prophylactic as well as therapeutic agents. For example, vaccines may be delivered using the device. In addition, the term refers broadly to active agents, such as nucleic acids, small molecules, therapeutic proteins, hormones, analgesics, etc. in additional to traditional pharmacologic agents. Typical drugs include peptides, proteins or hormones such as insulin, calcitonin, calcitonin gene regulating protein, atrial natriuretic protein, colony stimulating factor, betaseton, erythropoietin (EPO), interferons such as α, β, or γ interferon, somatropin, somatotropin, somatostatin, insulin-like growth factor (somatomedins), luteinizing hormone releasing hormone (LHRH), tissue plasminogen activator (TPA), growth hormone release hormone (GHRH), oxytocin, estradiol, growth hormones, leuprolide acetate, factor VIII, interleukins such as interleukin-2, and analogues thereof; analgesics such as fentanyl, sufentanil, butorphanol, buprenorphine, levorphanol, morphine, hydromorphone, hydrocodone, oxymorephone, methadone, lidocaine, bupivacaine, diclofenac, naproxen, pavefin, and analogues thereof; anti-migraine agents such as sumatriptan, ergot alkaloids, and analogues thereof, anti-coagulant agents such as hepafin, hirudin, and analogues thereof; anti-emetic agents such as scopolamine, ondansetron, domperidone, metoclopramide, and analogues thereof; cardiovascular agents, anti-hypertensive agents and vasodilator such as diltiazem, clonidine, nifedipine, verapamil, isosorbide-5-mononitrate, organic nitrates, agents used in treatment of heart disorders, and analogues thereof; sedatives such as benzodiazepines, phenothiozines, and analogues thereof; narcotic antagonists such as naltrexone, naloxone, and analogues thereof; chelating agents such as deferoxamine, and analogues thereof; anti-diuretic agents such as desmopressin, vasopressin, and analogues thereof; antineoplastics such as 5-fluorouracil, bleomycin, and analogues thereof; prostaglandins and analogues thereof; and chemotherapy agents such as vincristine, and analogues thereof. Stabilized preparations of drugs that can be stored at room temperature are particularly preferred for use in the device and method.
  • The term “fluid” refers to any fluid containing an active agent or communication of agents that can pass through the cannula of the microneedle. This includes a liquid, a solution, a gel, a dispersion or a fine suspension.
  • All citations are hereby incorporated by reference.
  • The present invention has been described with regard to one or more embodiments. However, it will be apparent to persons skilled in the art that a number of variations and modifications can be made without departing from the scope of the invention as defined in the claims.

Claims (32)

1. A reservoir for carrying an active agent, said reservoir comprising a fillable bladder of thermoplastic material.
2. A reservoir according to claim 1, wherein the reservoir is color coded to a specific drug.
3. A reservoir according to claim 1, wherein the bladder has a capacity of about 0.2 to 10 ml.
4. A reservoir according to claim 3, wherein the bladder has a capacity of about 0.3 to 6 ml.
5. A reservoir according to claim 4, wherein the bladder has a capacity of about 0.5 to 3 ml.
6. A method of manufacturing a reservoir as defined in claim 1, comprising the steps of:
i. providing at least one sheet having a depression formed therein and facing that sheet with a second sheet.
7. A method according to claim 6, further comprising the steps of:
i. filling the bubble with a fluid drug; and
ii. sealing the bubble.
8. A device for delivery of a fluid drug to an animal, said device comprising:
i. a housing having an upper end and a lower end, said lower end having an aperture therein and said upper end being associated with an actuator;
ii. a reservoir chamber disposed within the housing and operatively linked to the actuator, said reservoir chamber comprising a base and wall(s);
iii. a flexible reservoir, filled with the fluid drug, disposed within the reservoir chamber; and
iv. a needle mounted so as to transverse the base of said chamber such that a back of the needle is in communication with the chamber and a tip of the needle extends in the housing below the chamber.
9. A device according to claim 8, wherein the reservoir chamber is located at a predetermined distance from the lower end of the housing whereby abutment of the base of the chamber to the lower end of the housing acts as a stop to provide a predetermined length of travel of the needle through the aperture when the actuator is activated.
10. A device according to claim 9, wherein the length of travel of the needle is from about 0.5 mm to about 10 mm.
11. A device according to claim 9, wherein the length of travel of the needle is from about 1.5 mm to about 8 mm.
12. A device according to claim 9, wherein the length of travel of the needle is from about 3 mm to about 8 mm.
13. A device according to claim 8 wherein the actuator is a plunger comprising a plunger rod having an activation flange at one end and a stopper at the other end.
14. A device according to claim 8 further comprising biasing means to retain the needle with the housing in the absence of pressure on the drive mechanism.
15. A device according to claim 14 wherein the biasing means comprises an air bladder.
16. A device according to claim 14 wherein the biasing means comprises a spring.
17. A device according to claim 16 wherein the spring is disposed below the base of the reservoir chamber.
18. A device according to claim 16, wherein the spring is associated with the actuator.
19. A device according to claim 8 further including a piercable septum covering said aperture.
20. A method of administering a fluid drug through the skin of an animal, said method comprising:
i. providing a device as defined in claim 8;
ii. applying the lower surface of the device to the skin;
iii. exerting pressure on the drive mechanism thereby lowering the reservoir chamber and causing the needle tip to travel through the aperture and into the skin a predetermined distance; and
iv. applying continued pressure on the drive mechanism to cause the upper end of the needle to pierce the reservoir and the contents of the reservoir to flow through the needle into the skin.
21. A method according to claim 20 wherein the tip of needle is limited to travel a depth of 1.5 to 8 mm.
22. A method according to claim 20 wherein the needle travel is from about 1.5 to 3 mm.
23. A method according to claim 20 wherein the needle travel is from about 3 to 5 mm.
24. A method according to claim 20 wherein the needle travel is from about 5 to 8 mm.
25. A method according to claim 20 further comprising the step of retracting the needle back into the housing after use.
26. A method according to claim 25 whereby the step of retracting is done by biasing means automatically upon release of pressure on the drive mechanism.
27. A device for delivering an active agent to the skin, said device comprising:
i. a housing;
ii. a reservoir chamber releasably positioned in said housing, said reservoir chamber adapted to receive a reservoir containing the active agent;
iii. at least one needle having an upper opening and a lower opening defining a cannula transversing the base of the reservoir chamber; and
iv. actuator means for moving said chamber downward within said housing.
28. A device according to claim 27, wherein said reservoir chamber further comprises latch means for retaining said chamber in an upward position in the housing, said latch means adapted for release upon downward pressure on the actuator.
29. A device according to claim 28, wherein said latch means includes a tab and notch for connection to the actuator.
30. A device according to claim 29, wherein said actuator includes at least one notch for receiving a tab on said latch means.
31. A device according to claim 29, wherein said actuator includes an upper notch and a lower notch.
32. A device according to claim 29, wherein said upper notch receives said tab to lock said needle in a retracted position.
US11/355,000 2006-02-16 2006-02-16 Drug delivery device Abandoned US20070191780A1 (en)

Priority Applications (18)

Application Number Priority Date Filing Date Title
US11/355,000 US20070191780A1 (en) 2006-02-16 2006-02-16 Drug delivery device
CA002536845A CA2536845C (en) 2006-02-16 2006-02-16 Drug delivery device
BRPI0707845A BRPI0707845B8 (en) 2006-02-16 2007-02-15 drug delivery positive
ES07701776.2T ES2440247T3 (en) 2006-02-16 2007-02-15 Drug delivery device
DK07701776.2T DK1983964T3 (en) 2006-02-16 2007-02-15 DEVICE FOR THE ADMINISTRATION OF MEDICINAL PRODUCTS
JP2008554571A JP5099370B2 (en) 2006-02-16 2007-02-15 Drug supply device
PCT/CA2007/000225 WO2007093051A1 (en) 2006-02-16 2007-02-15 Drug delivery device
AU2007215343A AU2007215343B2 (en) 2006-02-16 2007-02-15 Drug delivery device
PL07701776T PL1983964T3 (en) 2006-02-16 2007-02-15 Drug delivery device
EP07701776.2A EP1983964B1 (en) 2006-02-16 2007-02-15 Drug delivery device
NZ570532A NZ570532A (en) 2006-02-16 2007-02-15 A housing containing a chamber with a flexible reservoir of active agents delivered via a needle to the skin
ZA200807006A ZA200807006B (en) 2006-02-16 2008-08-14 Drug delivery device
EC2008008681A ECSP088681A (en) 2006-02-16 2008-08-15 DRUG DISTRIBUTION DEVICE
US13/229,538 US8597257B2 (en) 2006-02-16 2011-09-09 Drug delivery device
US14/065,122 US20140207078A1 (en) 2006-02-16 2013-10-28 Drug delivery device
US14/562,974 US20150273152A1 (en) 2006-02-16 2014-12-08 Drug delivery device
US15/361,654 US20170203051A1 (en) 2006-02-16 2016-11-28 Drug delivery device
US16/543,051 US20200360625A1 (en) 2006-02-16 2019-08-16 Drug delivery device

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11/355,000 US20070191780A1 (en) 2006-02-16 2006-02-16 Drug delivery device
CA002536845A CA2536845C (en) 2006-02-16 2006-02-16 Drug delivery device

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US13/229,538 Continuation US8597257B2 (en) 2006-02-16 2011-09-09 Drug delivery device

Publications (1)

Publication Number Publication Date
US20070191780A1 true US20070191780A1 (en) 2007-08-16

Family

ID=38371151

Family Applications (6)

Application Number Title Priority Date Filing Date
US11/355,000 Abandoned US20070191780A1 (en) 2006-02-16 2006-02-16 Drug delivery device
US13/229,538 Active - Reinstated 2026-04-21 US8597257B2 (en) 2006-02-16 2011-09-09 Drug delivery device
US14/065,122 Abandoned US20140207078A1 (en) 2006-02-16 2013-10-28 Drug delivery device
US14/562,974 Abandoned US20150273152A1 (en) 2006-02-16 2014-12-08 Drug delivery device
US15/361,654 Abandoned US20170203051A1 (en) 2006-02-16 2016-11-28 Drug delivery device
US16/543,051 Pending US20200360625A1 (en) 2006-02-16 2019-08-16 Drug delivery device

Family Applications After (5)

Application Number Title Priority Date Filing Date
US13/229,538 Active - Reinstated 2026-04-21 US8597257B2 (en) 2006-02-16 2011-09-09 Drug delivery device
US14/065,122 Abandoned US20140207078A1 (en) 2006-02-16 2013-10-28 Drug delivery device
US14/562,974 Abandoned US20150273152A1 (en) 2006-02-16 2014-12-08 Drug delivery device
US15/361,654 Abandoned US20170203051A1 (en) 2006-02-16 2016-11-28 Drug delivery device
US16/543,051 Pending US20200360625A1 (en) 2006-02-16 2019-08-16 Drug delivery device

Country Status (13)

Country Link
US (6) US20070191780A1 (en)
EP (1) EP1983964B1 (en)
JP (1) JP5099370B2 (en)
AU (1) AU2007215343B2 (en)
BR (1) BRPI0707845B8 (en)
CA (1) CA2536845C (en)
DK (1) DK1983964T3 (en)
EC (1) ECSP088681A (en)
ES (1) ES2440247T3 (en)
NZ (1) NZ570532A (en)
PL (1) PL1983964T3 (en)
WO (1) WO2007093051A1 (en)
ZA (1) ZA200807006B (en)

Cited By (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060229570A1 (en) * 2002-09-11 2006-10-12 Becton, Dickinson And Company Injector device with force lock-out and injection rate limiting mechanisms
NL1036024C (en) * 2008-10-07 2010-04-08 Hubertus Eduard Hilbrink DEVICE AND METHOD FOR DELIVERING A LIQUID FROM A PACKAGING.
US20100249718A1 (en) * 2009-03-25 2010-09-30 Nipro Corporation Self-administration device for liquid medicine
WO2011034516A1 (en) * 2009-09-15 2011-03-24 Becton, Dickinson And Company Self-injection device
US20110172638A1 (en) * 2010-01-08 2011-07-14 Ratio, Inc. Drug delivery device including multi-functional cover
WO2011095494A1 (en) * 2010-02-02 2011-08-11 Clemenz, Markus Dermal access device
WO2011089206A3 (en) * 2010-01-22 2011-09-29 Sanofi-Aventis Deutschland Gmbh Coded collapsible drug reservoir
US20110233232A1 (en) * 2010-03-26 2011-09-29 Juergen Greiner-Perth Discharging device for liquids
US20120059326A1 (en) * 2009-04-09 2012-03-08 Korea Research Institute Of Bioscience And Biotechnology Microneedle Unit Capable of Controlling Fluid Delivery
WO2012059457A1 (en) * 2010-11-03 2012-05-10 Sanofi-Aventis Deutschland Gmbh Medicated module for administering fixed dose
US20120253314A1 (en) * 2011-03-30 2012-10-04 Ziv Harish Palm-controlled injectors
US20130006216A1 (en) * 2010-02-01 2013-01-03 Margaret Taylor Low dose prefilled drug delivery device and method
WO2013037743A1 (en) 2011-09-13 2013-03-21 Sanofi-Aventis Deutschland Gmbh Safety device and injection device
US20130184648A1 (en) * 2010-08-23 2013-07-18 Nanbu Plastics Co., Ltd. Percutaneous medication device and needle formation used for the device
GB2504827A (en) * 2012-06-07 2014-02-12 Consort Medical Plc Methods of manufacturing a rupturable propellant container
US8668675B2 (en) 2010-11-03 2014-03-11 Flugen, Inc. Wearable drug delivery device having spring drive and sliding actuation mechanism
US20140207104A1 (en) * 2011-07-25 2014-07-24 Lucien Vouillamoz Fluid dispenser
US20140228770A1 (en) * 2011-09-23 2014-08-14 Sanofi-Aventis Deutschland Gmbh Needle Safety Device
WO2015070914A1 (en) 2013-11-14 2015-05-21 Hahn-Schickard-Gesellschaft Fuer Angewandte Forschung E.V. Access device
US20160000646A1 (en) * 2014-07-07 2016-01-07 Mt.Derm Gmbh Application module for a handheld device for the repeated application of an application element to a human skin or to an animal skin, and handheld device
US20160175544A1 (en) * 2014-12-18 2016-06-23 Marc Andrew Koska Single use injection system
US20170007767A1 (en) * 2014-02-12 2017-01-12 Sanofi-Aventis Deutschland Gmbh Compressible reservoir for liquid medicament
US20170020727A1 (en) * 2014-04-04 2017-01-26 Sparkle Innovations B.V. Device and Method for Administering a Liquid Drop by Drop
US20170197031A1 (en) * 2014-06-04 2017-07-13 Merck Sharp & Dohme Corp. Prefilled disposable injection device
WO2017182530A1 (en) * 2016-04-19 2017-10-26 Philip Douglas Apparatus for administering liquid into skin
US9844629B2 (en) * 2011-05-18 2017-12-19 Becton, Dickinson And Company Injection device
US9931472B2 (en) 2012-04-17 2018-04-03 Universiteit Antwerpen Intradermal injection device
CN108553112A (en) * 2018-03-16 2018-09-21 苏杰 A kind of pig vaccine activity test method
US20190060166A1 (en) * 2014-04-30 2019-02-28 Sorrento Therapeutics, Inc. Cartridge portion of transdermal drug delivery apparatus and methods
CN111372630A (en) * 2017-11-21 2020-07-03 赛诺菲 Container for at least a first injectable medicament and injection device
CN112043954A (en) * 2019-06-05 2020-12-08 美帕信息科技(上海)有限公司 Newly born muscle leading-in instrument
US11123499B2 (en) * 2016-01-19 2021-09-21 Merck Sharp & Dohme Corp. Prefilled disposable injection device
US11247033B2 (en) * 2014-04-30 2022-02-15 Sorrento Therapeutics, Inc. Transdermal drug delivery apparatus and methods
US11413405B2 (en) 2016-04-01 2022-08-16 Idevax Bv Injection device
WO2022243082A1 (en) * 2021-05-21 2022-11-24 Shl Medical Ag Medicament delivery device
US11752068B2 (en) * 2017-10-19 2023-09-12 Sanofi Medicament container and drug delivery device

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1727576T3 (en) 2004-03-26 2009-07-06 Unomedical As Infusion
US8062250B2 (en) 2004-08-10 2011-11-22 Unomedical A/S Cannula device
US7985199B2 (en) 2005-03-17 2011-07-26 Unomedical A/S Gateway system
PL1762259T3 (en) 2005-09-12 2011-03-31 Unomedical As Inserter for an infusion set with a first and second spring units
ATE429260T1 (en) 2005-12-23 2009-05-15 Unomedical As ADMINISTRATION DEVICE
CA2536845C (en) 2006-02-16 2009-10-27 Pka Softtouch Corp. Drug delivery device
NZ570115A (en) 2006-02-28 2010-07-30 Unomedical As Inserter for infusion part and infusion part provided with needle protector
EP2023818A2 (en) 2006-06-07 2009-02-18 Unomedical A/S Inserter for transcutaneous sensor
CN101489604B (en) 2006-06-09 2012-05-23 优诺医疗有限公司 Mounting pad
CN101500627B (en) 2006-08-02 2012-03-14 优诺医疗有限公司 Cannula and delivery device
EP1917990A1 (en) 2006-10-31 2008-05-07 Unomedical A/S Infusion set
JP5337713B2 (en) * 2007-02-07 2013-11-06 ベクトン・ディキンソン・アンド・カンパニー Safety shield system and infusion device for single-use flexible compression syringes
DE202008017390U1 (en) 2007-06-20 2009-08-13 Unomedical A/S Catheter and device for making such a catheter
WO2009004026A1 (en) 2007-07-03 2009-01-08 Unomedical A/S Inserter having bistable equilibrium states
RU2010104457A (en) 2007-07-10 2011-08-20 Уномедикал А/С (Dk) TWO SPRING INPUT DEVICE
NZ587111A (en) 2008-02-13 2012-03-30 Unomedical As Infusion part including seal between cannula and fluid inlet or outlet
AU2009216703A1 (en) 2008-02-20 2009-08-27 Unomedical A/S Insertion device with horizontally moving part
CN102083377B (en) * 2008-06-19 2014-07-23 雷文达尔·贝蒂 A device for locating epidural space while safeguarding against dural puncture through differential friction technique
WO2010003886A1 (en) * 2008-07-07 2010-01-14 Unomedical A/S Inserter for transcutaneous device
KR20110127642A (en) 2008-12-22 2011-11-25 우노메디컬 에이/에스 Medical device comprising adhesive pad
KR20120054598A (en) 2009-07-30 2012-05-30 우노메디컬 에이/에스 Inserter device with horizontal moving part
CA2766961A1 (en) 2009-08-07 2011-02-10 Unomedical A/S Delivery device with sensor and one or more cannulas
US20110046559A1 (en) 2009-08-21 2011-02-24 Becton Dickinson France S.A.S. Syringe Assembly Having a Flexible or Slidable Flange
EP3184136B1 (en) 2010-03-25 2021-06-02 New Injection Systems Ltd Injector
BR112012024635A2 (en) 2010-03-30 2017-08-08 Unomedical As medical device
NZ702172A (en) * 2010-04-21 2016-03-31 Abbvie Biotechnology Ltd Wearable automatic injection device for controlled delivery of therapeutic agents
EP2433663A1 (en) 2010-09-27 2012-03-28 Unomedical A/S Insertion system
EP2436412A1 (en) 2010-10-04 2012-04-04 Unomedical A/S A sprinkler cannula
CA2816533A1 (en) * 2010-11-03 2012-10-05 Sanofi-Aventis Deutschland Gmbh Medicated module with deformable membrane
WO2013050277A1 (en) 2011-10-05 2013-04-11 Unomedical A/S Inserter for simultaneous insertion of multiple transcutaneous parts
EP2583715A1 (en) 2011-10-19 2013-04-24 Unomedical A/S Infusion tube system and method for manufacture
US9440051B2 (en) 2011-10-27 2016-09-13 Unomedical A/S Inserter for a multiplicity of subcutaneous parts
BR112015011662A2 (en) 2012-11-23 2017-07-11 New Injection Systems Ltd auto injector assembly
US20160228634A1 (en) * 2015-02-06 2016-08-11 Regeneron Pharmaceuticals, Inc. Aseptic drug delivery system and methods
ITUB20160615A1 (en) * 2016-02-10 2017-08-10 Orofino Pharmaceuticals Group Srl Cartridge and syringe for injection of a pharmaceutical solution and method for cartridge production
WO2018107270A1 (en) * 2016-12-15 2018-06-21 Pka Softtouch Corp. Intradermal drug delivery device having a locked post-dispensing configuration
US11771842B2 (en) * 2019-05-09 2023-10-03 Medicines360 Syringes, syringe containers, kits and methods of use

Citations (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2371086A (en) * 1940-11-14 1945-03-06 Watson Hypodermic injector
US3527215A (en) * 1967-02-20 1970-09-08 American Hospital Supply Corp Syringe construction having internal bladder
US4883473A (en) * 1987-04-29 1989-11-28 Path Single use injection device
US4886499A (en) * 1986-12-18 1989-12-12 Hoffmann-La Roche Inc. Portable injection appliance
US4955871A (en) * 1987-04-29 1990-09-11 Path Single-use disposable syringe
US5527288A (en) * 1990-12-13 1996-06-18 Elan Medical Technologies Limited Intradermal drug delivery device and method for intradermal delivery of drugs
US5658259A (en) * 1995-10-19 1997-08-19 Meridian Medical Technologies, Inc. Dental cartridge assembly auto-injector with protective needle cover
US5964736A (en) * 1995-09-22 1999-10-12 Lane; Donovan R. Livestock biological and vaccine handling system
US5997501A (en) * 1993-11-18 1999-12-07 Elan Corporation, Plc Intradermal drug delivery device
US6102896A (en) * 1999-09-08 2000-08-15 Cambridge Biostability Limited Disposable injector device
US6387078B1 (en) * 2000-12-21 2002-05-14 Gillespie, Iii Richard D. Automatic mixing and injecting apparatus
US6494865B1 (en) * 1999-10-14 2002-12-17 Becton Dickinson And Company Intradermal delivery device including a needle assembly
US6569143B2 (en) * 1999-10-14 2003-05-27 Becton, Dickinson And Company Method of intradermally injecting substances
US6607509B2 (en) * 1997-12-31 2003-08-19 Medtronic Minimed, Inc. Insertion device for an insertion set and method of using the same
US6620134B1 (en) * 1998-11-23 2003-09-16 Medrad, Inc. Syringes and injector systems with collapsible cartridges
US6689118B2 (en) * 1999-10-14 2004-02-10 Becton Dickinson And Company Method of intradermally injecting substances
US6808507B2 (en) * 2002-05-10 2004-10-26 Cambridge Biostability Ltd. Safety injectors
US20050124967A1 (en) * 1999-10-14 2005-06-09 Kaestner Scott A. Method and device for delivery of high molecular weight substances
US6979316B1 (en) * 2002-05-23 2005-12-27 Seedlings Life Science Ventures Llc Apparatus and method for rapid auto-injection of medication
US20060229562A1 (en) * 2005-04-11 2006-10-12 Marsh Ronald W Injection device with secondary reservoir

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2667872A (en) * 1952-03-19 1954-02-02 Arthur E Smith Syringe unit
US3255752A (en) * 1965-01-28 1966-06-14 Dick Peter Hypodermic syringe
US4258713A (en) * 1979-07-23 1981-03-31 Wardlaw Stephen C Automatic disposable hypodermic syringe
ATA228987A (en) * 1987-09-09 1993-07-15 Pickhard Ewald INJECTION DEVICE WITH A DEFORMABLE Vial
US4925055A (en) * 1988-03-04 1990-05-15 Edward S. Robbins, III Container with unitary bladder and associated dispenser cap
KR910004532Y1 (en) * 1989-06-15 1991-06-29 방영철 Syringe
CA2126320C (en) * 1992-01-24 2006-09-05 Kenneth W. Rake Platen pump
CA2132277C (en) * 1993-10-22 2005-05-10 Giorgio Cirelli Injection device
US5413564A (en) * 1994-03-02 1995-05-09 Silver; Jules Predetermined dosage hypodermic syringe system
EP0695554B1 (en) * 1994-07-27 1999-01-07 Meridian Medical Technologies, Inc. Automatic injector
CA2159052C (en) * 1994-10-28 2007-03-06 Rainer Alex Injection device
JPH09173450A (en) * 1995-12-26 1997-07-08 Nissho Corp Prefilled syringe
JPH10174717A (en) * 1996-12-18 1998-06-30 Daikyo Seiko:Kk Injector assembly
AUPP313398A0 (en) * 1998-04-22 1998-05-14 Boston Research And Development Company Disposable fluid or particulate applicator
GB2351272B (en) * 1999-06-23 2001-05-02 Eu Pharma Ltd Oral medicine dispenser
US6585698B1 (en) * 1999-11-01 2003-07-01 Becton, Dickinson & Company Electronic medical delivery pen having a multifunction actuator
AT411222B (en) * 2001-10-31 2003-11-25 Juette Werner Dr DISPOSABLE INJECTION DEVICE
US6896666B2 (en) * 2002-11-08 2005-05-24 Kochamba Family Trust Cutaneous injection delivery under suction
EP1452196A1 (en) * 2003-02-25 2004-09-01 Jean-Denis Rochat Device and method of making the package of medicament
GB0414054D0 (en) * 2004-06-23 2004-07-28 Owen Mumford Ltd Improvements relating to automatic injection devices
US7640758B2 (en) 2005-02-16 2010-01-05 Zero Zone, Inc. Refrigerant tracking/leak detection system and method
FR2884721A1 (en) * 2005-04-20 2006-10-27 Becton Dickinson France Soc Pa Assistance device for device of injection of a product, comprises hollow body for receiving the product, hollow injection needle for penetrating into injection site, piston placed in the body, hollow sleeve with bearing surface
CA2536845C (en) 2006-02-16 2009-10-27 Pka Softtouch Corp. Drug delivery device

Patent Citations (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2371086A (en) * 1940-11-14 1945-03-06 Watson Hypodermic injector
US3527215A (en) * 1967-02-20 1970-09-08 American Hospital Supply Corp Syringe construction having internal bladder
US4886499A (en) * 1986-12-18 1989-12-12 Hoffmann-La Roche Inc. Portable injection appliance
US4883473A (en) * 1987-04-29 1989-11-28 Path Single use injection device
US4955871A (en) * 1987-04-29 1990-09-11 Path Single-use disposable syringe
US5527288A (en) * 1990-12-13 1996-06-18 Elan Medical Technologies Limited Intradermal drug delivery device and method for intradermal delivery of drugs
US5997501A (en) * 1993-11-18 1999-12-07 Elan Corporation, Plc Intradermal drug delivery device
US5964736A (en) * 1995-09-22 1999-10-12 Lane; Donovan R. Livestock biological and vaccine handling system
US5658259A (en) * 1995-10-19 1997-08-19 Meridian Medical Technologies, Inc. Dental cartridge assembly auto-injector with protective needle cover
US6607509B2 (en) * 1997-12-31 2003-08-19 Medtronic Minimed, Inc. Insertion device for an insertion set and method of using the same
US6620134B1 (en) * 1998-11-23 2003-09-16 Medrad, Inc. Syringes and injector systems with collapsible cartridges
US6102896A (en) * 1999-09-08 2000-08-15 Cambridge Biostability Limited Disposable injector device
US6689118B2 (en) * 1999-10-14 2004-02-10 Becton Dickinson And Company Method of intradermally injecting substances
US6569143B2 (en) * 1999-10-14 2003-05-27 Becton, Dickinson And Company Method of intradermally injecting substances
US6494865B1 (en) * 1999-10-14 2002-12-17 Becton Dickinson And Company Intradermal delivery device including a needle assembly
US20050124967A1 (en) * 1999-10-14 2005-06-09 Kaestner Scott A. Method and device for delivery of high molecular weight substances
US6387078B1 (en) * 2000-12-21 2002-05-14 Gillespie, Iii Richard D. Automatic mixing and injecting apparatus
US6808507B2 (en) * 2002-05-10 2004-10-26 Cambridge Biostability Ltd. Safety injectors
US6979316B1 (en) * 2002-05-23 2005-12-27 Seedlings Life Science Ventures Llc Apparatus and method for rapid auto-injection of medication
US20060229562A1 (en) * 2005-04-11 2006-10-12 Marsh Ronald W Injection device with secondary reservoir

Cited By (74)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060229570A1 (en) * 2002-09-11 2006-10-12 Becton, Dickinson And Company Injector device with force lock-out and injection rate limiting mechanisms
US9486581B2 (en) 2002-09-11 2016-11-08 Becton, Dickinson And Company Injector device with force lock-out and injection rate limiting mechanisms
US9144515B2 (en) 2008-10-07 2015-09-29 Sparkle Innovations B.V. Device and method for administering a liquid drop-by-drop
NL1036024C (en) * 2008-10-07 2010-04-08 Hubertus Eduard Hilbrink DEVICE AND METHOD FOR DELIVERING A LIQUID FROM A PACKAGING.
WO2010041941A1 (en) * 2008-10-07 2010-04-15 Hubertus Eduard Hilbrink Device and method for administering a liquid drop by drop
US20110208138A1 (en) * 2008-10-07 2011-08-25 Hilbrink Hubertus E Device and method for administering a liquid drop-by-drop
CN102186439A (en) * 2008-10-07 2011-09-14 许贝特斯·爱德华·希尔布瑞克 Device and method for administering a liquid drop by drop
US20100249718A1 (en) * 2009-03-25 2010-09-30 Nipro Corporation Self-administration device for liquid medicine
US8845591B2 (en) * 2009-03-25 2014-09-30 Nipro Corporation Self-administration device for liquid medicine
US20120059326A1 (en) * 2009-04-09 2012-03-08 Korea Research Institute Of Bioscience And Biotechnology Microneedle Unit Capable of Controlling Fluid Delivery
US9022997B2 (en) * 2009-04-09 2015-05-05 Korea Research Institute Of Bioscience And Biotechnology Microneedle unit capable of controlling fluid delivery
JP2012523265A (en) * 2009-04-09 2012-10-04 コリア リサーチ インスティチュート オブ バイオサイエンス アンド バイオテクノロジー Microneedle unit capable of adjusting fluid transmission
US9408984B2 (en) * 2009-09-15 2016-08-09 Becton, Dickinson And Company Self-injection device
WO2011034516A1 (en) * 2009-09-15 2011-03-24 Becton, Dickinson And Company Self-injection device
CN102596285A (en) * 2009-09-15 2012-07-18 贝克顿·迪金森公司 Self-injection device
US20120245558A1 (en) * 2009-09-15 2012-09-27 Durack David T Self-injection device
US20110172638A1 (en) * 2010-01-08 2011-07-14 Ratio, Inc. Drug delivery device including multi-functional cover
WO2011089206A3 (en) * 2010-01-22 2011-09-29 Sanofi-Aventis Deutschland Gmbh Coded collapsible drug reservoir
US11147739B2 (en) 2010-01-22 2021-10-19 Sanofi-Aventis Deutschland Gmbh Coded collapsible drug reservoir
US10130558B2 (en) * 2010-01-22 2018-11-20 Sanofi-Aventis Deutschland Gmbh Coded collapsible drug reservoir
US20130072878A1 (en) * 2010-01-22 2013-03-21 Sanofi-Avenits Deutschland Gmbh Coded Collapsible Drug Reservoir
US9849247B2 (en) * 2010-02-01 2017-12-26 Becton, Dickinson And Company Low dose prefilled drug delivery device and method
CN105536109B (en) * 2010-02-01 2021-04-09 贝克顿·迪金森公司 Low dose pre-filled drug delivery device and method
US10898648B2 (en) * 2010-02-01 2021-01-26 Becton, Dickinson And Company Low dose prefilled drug delivery device and method
CN105536109A (en) * 2010-02-01 2016-05-04 贝克顿·迪金森公司 Low dose prefilled drug delivery device and method
US20130006216A1 (en) * 2010-02-01 2013-01-03 Margaret Taylor Low dose prefilled drug delivery device and method
US11738150B2 (en) 2010-02-01 2023-08-29 Becton, Dickinson And Company Low dose prefilled drug delivery device and method
US20180085527A1 (en) * 2010-02-01 2018-03-29 Becton, Dickinson And Company Low dose prefilled drug delivery device and method
US9174006B2 (en) 2010-02-02 2015-11-03 Hahn-Schickard-Gesellschaft Fur Angewandte Forschung E.V. Dermal access device
WO2011095494A1 (en) * 2010-02-02 2011-08-11 Clemenz, Markus Dermal access device
US20110233232A1 (en) * 2010-03-26 2011-09-29 Juergen Greiner-Perth Discharging device for liquids
EP2371341A1 (en) * 2010-03-26 2011-10-05 Ing. Erich Pfeiffer GmbH Discharge device for liquids
US20130184648A1 (en) * 2010-08-23 2013-07-18 Nanbu Plastics Co., Ltd. Percutaneous medication device and needle formation used for the device
EP2608824A4 (en) * 2010-08-23 2017-11-08 Nanbu Plastics Co., Ltd. A percutaneous medication device and a needle formation used for the device
US9808583B2 (en) * 2010-08-23 2017-11-07 Nanbu Plastics Co., Ltd. Percutaneous medication device and needle formation used for the device
US9180253B2 (en) 2010-11-03 2015-11-10 Sanofi-Aventis Deutschland Gmbh Medicated module for administering fixed dose
WO2012059457A1 (en) * 2010-11-03 2012-05-10 Sanofi-Aventis Deutschland Gmbh Medicated module for administering fixed dose
US8668675B2 (en) 2010-11-03 2014-03-11 Flugen, Inc. Wearable drug delivery device having spring drive and sliding actuation mechanism
US20120253314A1 (en) * 2011-03-30 2012-10-04 Ziv Harish Palm-controlled injectors
US9844629B2 (en) * 2011-05-18 2017-12-19 Becton, Dickinson And Company Injection device
US20140207104A1 (en) * 2011-07-25 2014-07-24 Lucien Vouillamoz Fluid dispenser
US9821116B2 (en) * 2011-07-25 2017-11-21 Preciflex Sa Fluid dispenser
US9669170B2 (en) 2011-09-13 2017-06-06 Sanofi-Aventis Deutschland Gmbh Safety device and injection device
WO2013037743A1 (en) 2011-09-13 2013-03-21 Sanofi-Aventis Deutschland Gmbh Safety device and injection device
US20140228770A1 (en) * 2011-09-23 2014-08-14 Sanofi-Aventis Deutschland Gmbh Needle Safety Device
US9931472B2 (en) 2012-04-17 2018-04-03 Universiteit Antwerpen Intradermal injection device
US20150151045A1 (en) * 2012-06-07 2015-06-04 Consort Medical Plc Method of manufacturing a propellant container
GB2504827A (en) * 2012-06-07 2014-02-12 Consort Medical Plc Methods of manufacturing a rupturable propellant container
US10398856B2 (en) 2013-11-14 2019-09-03 Hahn-Schickard-Gesellschaft Fuer Angewandte Forschung E.V. Access device
WO2015070914A1 (en) 2013-11-14 2015-05-21 Hahn-Schickard-Gesellschaft Fuer Angewandte Forschung E.V. Access device
US11419984B2 (en) * 2014-02-12 2022-08-23 Sanofi-Aventis Deutschland Gmbh Compressible reservoir for liquid medicament
US20170007767A1 (en) * 2014-02-12 2017-01-12 Sanofi-Aventis Deutschland Gmbh Compressible reservoir for liquid medicament
US10639192B2 (en) * 2014-04-04 2020-05-05 Sparkle Innovations B.V. Device and method for administering a liquid drop by drop
US20170020727A1 (en) * 2014-04-04 2017-01-26 Sparkle Innovations B.V. Device and Method for Administering a Liquid Drop by Drop
US20190060166A1 (en) * 2014-04-30 2019-02-28 Sorrento Therapeutics, Inc. Cartridge portion of transdermal drug delivery apparatus and methods
AU2021204301B2 (en) * 2014-04-30 2023-08-24 Sorrento Therapeutics, Inc. Transdermal drug delivery apparatus and methods
US11247033B2 (en) * 2014-04-30 2022-02-15 Sorrento Therapeutics, Inc. Transdermal drug delivery apparatus and methods
CN109675133A (en) * 2014-04-30 2019-04-26 索伦托治疗有限公司 Drug delivery device
US10940085B2 (en) * 2014-04-30 2021-03-09 Sorrento Therapeutics, Inc. Cartridge portion of transdermal drug delivery apparatus and methods
AU2020200628B2 (en) * 2014-04-30 2021-03-11 Sorrento Therapeutics, Inc. Cartridge portion of transdermal drug delivery apparatus and methods
US10543317B2 (en) * 2014-06-04 2020-01-28 Merck Sharp & Dohme Corp. Prefilled disposable injection device
US20170197031A1 (en) * 2014-06-04 2017-07-13 Merck Sharp & Dohme Corp. Prefilled disposable injection device
US20160000646A1 (en) * 2014-07-07 2016-01-07 Mt.Derm Gmbh Application module for a handheld device for the repeated application of an application element to a human skin or to an animal skin, and handheld device
US20160175544A1 (en) * 2014-12-18 2016-06-23 Marc Andrew Koska Single use injection system
US11123499B2 (en) * 2016-01-19 2021-09-21 Merck Sharp & Dohme Corp. Prefilled disposable injection device
US20220001116A1 (en) * 2016-01-19 2022-01-06 Merck Sharp & Dohme Corp. Prefilled disposable injection device
US11878158B2 (en) * 2016-01-19 2024-01-23 Merck Sharp & Dohme Llc Prefilled disposable injection device
US11413405B2 (en) 2016-04-01 2022-08-16 Idevax Bv Injection device
WO2017182530A1 (en) * 2016-04-19 2017-10-26 Philip Douglas Apparatus for administering liquid into skin
US11752068B2 (en) * 2017-10-19 2023-09-12 Sanofi Medicament container and drug delivery device
CN111372630A (en) * 2017-11-21 2020-07-03 赛诺菲 Container for at least a first injectable medicament and injection device
CN108553112A (en) * 2018-03-16 2018-09-21 苏杰 A kind of pig vaccine activity test method
CN112043954A (en) * 2019-06-05 2020-12-08 美帕信息科技(上海)有限公司 Newly born muscle leading-in instrument
WO2022243082A1 (en) * 2021-05-21 2022-11-24 Shl Medical Ag Medicament delivery device

Also Published As

Publication number Publication date
US20140207078A1 (en) 2014-07-24
WO2007093051A1 (en) 2007-08-23
EP1983964B1 (en) 2013-10-09
ES2440247T3 (en) 2014-01-28
CA2536845C (en) 2009-10-27
JP2009526575A (en) 2009-07-23
US20110319834A1 (en) 2011-12-29
NZ570532A (en) 2011-09-30
US8597257B2 (en) 2013-12-03
ZA200807006B (en) 2009-10-28
AU2007215343A1 (en) 2007-08-23
BRPI0707845B8 (en) 2021-06-22
US20200360625A1 (en) 2020-11-19
DK1983964T3 (en) 2014-01-20
AU2007215343B2 (en) 2012-08-23
BRPI0707845B1 (en) 2020-08-25
ECSP088681A (en) 2008-10-31
BRPI0707845A2 (en) 2011-05-10
PL1983964T3 (en) 2014-03-31
US20150273152A1 (en) 2015-10-01
CA2536845A1 (en) 2007-08-16
BRPI0707845A8 (en) 2018-10-30
EP1983964A4 (en) 2009-04-08
EP1983964A1 (en) 2008-10-29
US20170203051A1 (en) 2017-07-20
JP5099370B2 (en) 2012-12-19

Similar Documents

Publication Publication Date Title
US20200360625A1 (en) Drug delivery device
US20030109827A1 (en) Drug delivery system and method
EP1379299B1 (en) Prefillable intradermal injector
US9682198B2 (en) Intradermal injection device
US6569123B2 (en) Prefillable intradermal injector
US6099504A (en) Pre-filled injection delivery device
AU2001297971A1 (en) Prefillable intradermal injector
US20020177808A1 (en) Mechanism for prevention of premature activation
ZA200307922B (en) Prefillable intradermal injector.

Legal Events

Date Code Title Description
AS Assignment

Owner name: PKA SOFTTOUCH CORP., CANADA

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:MODI, PANKAJ;REEL/FRAME:017641/0061

Effective date: 20060419

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION